In NASH, the increased inflammatory response leads to an increase in inflammatory factors, such as interleukin-6 (IL-6)3 and tumor necrosis factor-α (TNF-α), which in turn leads to an increase in the SOCS3 expression [27]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatohepatitis.